Updates

Press & Publications

News, updates, media features, and scientific breakthroughs from our Founders: Prof. Kartik Sunagar at the Evolutionary Venomics Lab, IISc and Dr Vinay Prabhu.

Jan 2026
Company Milestone

Venomics AI Conceptualized

Kartik and Vinay met in India after 15 years and Venomics AI was conceptualized.

Apr 2026
Funding

$3M Funding Raised

Venomics AI has managed to raise $3M in funding on 10th April 2026.

Feb 2024
The Hindu / STM

IISc researchers develop synthetic antibody to neutralise snake bite toxins

Researchers at the Evolutionary Venomics Lab, led by Dr. Kartik Sunagar, have successfully developed a broadly neutralizing antibody that targets conserved regions of snake venom neurotoxins across multiple highly venomous species. This marks a major paradigm shift away from traditional horse-serum antivenoms.

Read Full Article ↗
Jan 2024
Nature India

Mapping India's untamed venomous biodiversity

A massive pan-India expedition spearheaded by Dr. Sunagar is decoding the venom profiles of the nation's most medically significant yet neglected snake species. The undertaking aims to overhaul century-old antivenom production methods by leveraging cutting-edge omics and establishing the subcontinent's definitive venom library.

Read Full Article ↗
Aug 2021
PLoS Neglected Tropical Diseases

Biogeographical venom variation in Russell’s viper underscores preclinical inefficacy

A landmark study revealing dramatic geographical variations in the venom composition of the Russell's viper across the Indian subcontinent. Dr. Sunagar's research highlighted that commercial antivenoms fail to neutralize the venom of vipers from certain regions, strongly advocating for next-generation, regionally tailored or broadly neutralizing therapies.

View Publication ↗
Dec 2019
PLoS Neglected Tropical Diseases

Beyond the 'big four': Venom profiling of medically important yet neglected Indian snakes

Dr. Sunagar and his team systematically profiled the venoms of neglected snake species responsible for significant morbidity in India. The findings proved that focusing solely on the "Big Four" snake species leaves millions vulnerable to bites from other highly toxic species, cementing the lab's foundational mission to modernize venom therapeutics.

View Publication ↗